Unlock instant, AI-driven research and patent intelligence for your innovation.

Microfluidic system for simulating lung tissue

A microfluidic system and lung-simulating technology, applied in tissue culture, tissue cell/virus culture devices, bone/connective tissue cells, etc., can solve problems such as cell death, and achieve the effect of in vitro diagnosis and customized drug prescription

Pending Publication Date: 2022-08-05
首尔大学校医院
View PDF0 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

For example, animal models do not exhibit the tracheal and lung-related pathological abnormalities often found in humans, and most in vitro models fail to mimic the tissue composition and structural complexity that actually differentiate into various tracheal epithelial cells
Further, as described above, the in vitro model of the simulated lung must be exposed to gas including oxygen for research, but currently marketed in vitro models made of cells, such as other Cells will die within 3 days, so it is not suitable for a series of steps such as model making, drug effect exploration, and drug toxicity screening that require at least 7 days

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Microfluidic system for simulating lung tissue
  • Microfluidic system for simulating lung tissue
  • Microfluidic system for simulating lung tissue

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0061] Example 1 Isolation of lung epithelial cells and lung fibroblasts from human lung tissue

[0062] To fabricate a microfluidic system that mimics in vivo lung tissue, lung epithelial cells and lung fibroblasts were isolated from human lung tissue by the following method.

Embodiment 1-1

[0063] Example 1-1 Dissociation of human lung tissue

[0064] 10 normal lung tissue samples (N-1 to N-10) of 0.39 g to 1.37 g in Table 1 below obtained from normal lung tissue in resected lung tissue of lung cancer patients who had undergone surgery, and from lung cancer patients 2 lung cancer tissue samples (C-1 and C-2) with a total of 0.41 g in Table 1 below obtained from cancer tissue in resected lung tissue were stored in storage buffer (MiltenyiBiotec, Tissue Storage Solution) at 4°C for 1 From day to day 2, these tissue samples were then divided into 0.4g to 0.5g each and put into each C tube (C test tube) respectively.

[0065] 【Table 1】

[0066] tissue sample number Weight (g) tissue sample number Weight (g) N-1 0.54 N-7 1.37 N-2 0.52 N-8 0.64 N-3 0.66 N-9 1.00 N-4 0.70 N-10 0.39 N-5 1.02 C-1 *

0.28 N-6 1.17 C-2 *

0.13

[0067] *The total weight of lung cancer tissue samples C-1 and C-2 was 0.41 g, ...

Embodiment 1-2

[0071] Example 1-2 Isolation of lung epithelial cells and lung fibroblasts

[0072] Human lung tissue dissociated in Example 1-1 Lung epithelial cells and lung fibroblasts were isolated by the procedure described below.

[0073] Specifically, calculate the number of cells contained in the T-175 flask in Example 1-1, prepare 5X10 6 to 1X10 7The cells were centrifuged at 300×g for 10 minutes at room temperature to prepare three suspensions of cell clumps, ie, a total of 300ul of lung epithelial cell suspension and a total of 80ul of lung fibroblast suspension. At this time, the autoMACS Rinsing solution (Miltenyi Biotec, #130-091-222) and the MACS BSA stock (stock) solution (Miltenyi Biotec, #130-091-376) were combined at a volume ratio of 20:1, that is, using the The three suspensions were prepared with PEB buffer obtained by mixing 47.5 ml of autoMACS wash solution and 2.5 ml of MACS BSA stock solution.

[0074] Then, in order to improve the purity of the isolated cells, 10...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a bionic system for simulating lung tissue, a manufacturing method of the bionic system and a method for controlling microfluid by using the bionic system, the bionic system comprises lung epithelial cells, lung fibroblasts and human umbilical vein vascular endothelial cells which are separated from human lungs, and microfluid is perfused in the bionic system. The chambers inside the system can be perfused with a gas and a fluid including a culture solution, respectively, and similar respiratory movements can be simulated, even after the fluid is perfused for more than one week, the three cells inside the system can survive. In addition, a pH measuring sensor and a gas partial pressure measuring sensor in the system can be used for monitoring the pH and pO2 in the chamber, so that the three cells in the system are exposed to the external environment or drugs and the like under the same conditions as the lung in a living body. Therefore, researches in wide fields including modeling of lung diseases caused by harmful substances, efficacy testing of therapeutic drugs and the like can be realized, and the method is further applicable to in-vitro disease modeling and customization of drug prescriptions.

Description

technical field [0001] The invention provides a microfluidic system for simulating lung tissue, a manufacturing method thereof, and a microfluidic control method using the microfluidic system. The microfluidic system includes lung epithelial cells and lung fibroblasts isolated from human lungs and human umbilical vein endothelial cells perfused with microfluidics. [0002] 【National research and development projects supporting the present invention】 [0003] 【The unique number of the project】16C1787 [0004] 【Department Name】Ministry of Health and Welfare [0005] 【Specialized organization for research management】Korea Health Industry Promotion Institute [0006] 【Research project name】Disease treatment related technology development [0007] 【Research topic】Clinical effects of new drug candidates for acute lung injury based on biomimetic chips [0008] 【Contribution rate】1 / 1 [0009] 【Organization】Bundang Seoul National University Hospital [0010] 【Research period】201...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C12M3/06C12M1/00C12M1/12C12M1/34C12N5/071
CPCC12N5/0656C12N5/069C12N5/0688C12N5/0068C12N2531/00C12N2533/90C12M23/16C12M21/08C12M25/02C12M41/40C12M29/10C12N5/0062C12M23/22C12M25/16C12M41/26
Inventor 曹永再朴美英鱼夽映
Owner 首尔大学校医院